Fusion Pharmaceuticals Inc (DELISTED) (FUSN:DL)
21.55
0.00 (0.00%)
USD |
NASDAQ |
Jun 04, 16:00
Fusion Pharmaceuticals Stock Buybacks (Quarterly): -48.47M for March 31, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -48.47M |
December 31, 2023 | -57.27M |
September 30, 2023 | -0.045M |
June 30, 2023 | -24.44M |
March 31, 2023 | -63.37M |
December 31, 2022 | -0.132M |
September 30, 2022 | -3.981M |
June 30, 2022 | -0.074M |
March 31, 2022 | -1.627M |
December 31, 2021 | 0.00 |
Date | Value |
---|---|
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | -197.62M |
March 31, 2020 | |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-197.62M
Minimum
Jun 2020
--
Maximum
Sep 2019
-22.06M
Average
-0.0595M
Median
Stock Buybacks (Quarterly) Benchmarks
AstraZeneca PLC | -5.00M |
Landos Biopharma Inc (DELISTED) | 0.00 |
Acasti Pharma Inc | -- |
Aurinia Pharmaceuticals Inc | 6.134M |
Edesa Biotech Inc | -0.1384M |